MedX Health Corp. MDXHF
0.03
0.00
0.00%
as of 24 Sep
- Market cap
- $103.2M
- P/E
- 0.0×
Follow MDXHF
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
53.97% | 54.70% | 68.26% | 63.45% | |
| (502.09%) | (487.89%) | (784.32%) | (867.29%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
61.42% | 61.68% | 66.31% | 73.83% | |
Average Days of Receivables |
322.38 | 359.84 | 97.93 | 66.93 | |
Free Cash Flow per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Free Cash Flow |
(3.54) | (3.59) | (3.77) | (3.91) | |
Capital Expenditures |
(1.24) | (1.29) | (1.10) | (0.99) | |
Piotroski F-Score |
4.00 | 4.00 | 3.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
61.52% | 53.30% | 46.48% | 62.40% | |
Accounts Receivable Turnover |
1.46 | 1.36 | 2.22 | 2.56 | |
Accounts Payable Turnover |
0.12 | 0.13 | 0.22 | 0.22 | |
Inventory Turnover |
0.76 | 0.85 | 1.85 | 2.17 | |
Average Days of Payables |
2,980.83 | 2,984.39 | 1,699.98 | 1,656.79 | |
Days of Inventory on Hand |
496.47 | 422.37 | 130.14 | 93.85 | |
Tax Rate |
0.00 | 0.14 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
106.06% | 96.80% | 105.64% | 95.81% | |
Selling, General and Administrative Expense of Revenue |
540.71% | 570.55% | 789.58% | 639.69% | |
Share Based Compensation of Revenue |
144.53% | 135.77% | 183.15% | 52.33% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.68 | 0.61 | 0.59 | 0.68 | |
Depreciation/Fixed assets |
2.83 | 0.15 | 0.18 | 0.20 | |
Capex/Depreciation |
(36.85) | (37.54) | (29.85) | (24.40) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
3.62 | 3.45 | 3.26 | 2.53 | |
Net Profit Margin |
(980.05%) | (1,009.73%) | (1,328.81%) | (1,094.99%) |
Columns are period end dates